Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-LEVOMILNACIPRAN DIN 02564858

Status: Approved
Holder: APOTEX INC
Molecule: LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)

Health Canada record

Active ingredient(s)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 40 MG
Dosage formCapsule (Extended-Release)
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN06AX28 LEVOMILNACIPRAN
Original market date
Current status date21-Jan-2026
SourceHealth Canada DPD

Establishment licence of the holder

Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)

DINProductCompanyFormStrengthStatus
02564831APO-LEVOMILNACIPRANAPOTEX INCCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 20 MGApproved
02564866APO-LEVOMILNACIPRANAPOTEX INCCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 80 MGApproved
02564874APO-LEVOMILNACIPRANAPOTEX INCCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 120 MGApproved
02440970FETZIMAABBVIE CORPORATIONCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 20 MGMarketed
02441004FETZIMAABBVIE CORPORATIONCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 120 MGMarketed
02440989FETZIMAABBVIE CORPORATIONCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 40 MGMarketed
02440997FETZIMAABBVIE CORPORATIONCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 80 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
367632026-01-21Abbreviated New Drug Submission (ANDS)
Request a quote for APO-LEVOMILNACIPRAN

How to read a Canadian DIN record